Insulet (PODD) Posts Breakeven Q1
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $147.48 -2.06%
Revenue Growth %: +18.1%
Financial Fact:
Cost of revenue: 39.23M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +18.1%
Financial Fact:
Cost of revenue: 39.23M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q1 EPS of $0.00, which may not compare to the analyst estimate of $0.07. Revenue for the quarter came in at $252.3 million versus the consensus estimate of $247.16 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell
- Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
